GH Research (GHRS) Liabilities and Shareholders Equity (2021 - 2025)

GH Research (GHRS) recorded quarterly Liabilities and Shareholders Equity of $288.2 million in Q4 2025, down 4.57% quarter-over-quarter from $302.0 million in Q3 2025, and up 53.09% on a YoY basis from $188.3 million in Q4 2024.

GH Research (GHRS) Liabilities and Shareholders Equity (2021 - 2025) Analysis & Trends

GH Research's Liabilities and Shareholders Equity history runs 5 years deep, the most recent figure standing at $288.2 million for Q4 2025.

  • In Q4 2025, Liabilities and Shareholders Equity rose 53.09% year-over-year to $288.2 million; the TTM figure through Dec 2025 stood at $1.2 billion (up 50.67% YoY), while the FY2025 annual figure was $288.2 million, up 53.09% from the prior year.
  • Liabilities and Shareholders Equity was $288.2 million for Q4 2025 at GH Research, down from $302.0 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $320.5 million in Q1 2025 to a low of $188.3 million in Q4 2024.
  • Historically, Liabilities and Shareholders Equity has averaged $256.3 million across 5 years, with a median of $257.2 million in 2022.
  • The sharpest annual moves came in 2024 and 2025: Liabilities and Shareholders Equity fell 16.8% in 2024, then soared 53.09% in 2025.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $288.1 million in 2021, then slipped by 11.71% to $254.4 million in 2022, then declined by 11.03% to $226.3 million in 2023, then declined by 16.8% to $188.3 million in 2024, then jumped by 53.09% to $288.2 million in 2025.
  • The last three Liabilities and Shareholders Equity figures came in at $288.2 million (Q4 2025), $302.0 million (Q3 2025), and $313.4 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - 37.37 Mn
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - 811.27 Mn
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - 14.93 Mn
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn 1.73 Bn
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - 33.89 Mn
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - 23.64 Mn
7 Psyence Biomedical 241.78 Bn 241.78 Bn - 12.81 Mn
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 26.48 Bn
9 Abivax 94.26 Bn 94.26 Bn - 640.56 Mn
10 GH Research 9.73 Bn 9.63 Bn - 288.23 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 288.23 Mn
Sep 30, 2025 302.02 Mn
Jun 30, 2025 313.43 Mn
Mar 31, 2025 320.45 Mn
Dec 31, 2024 188.27 Mn
Sep 30, 2024 199.61 Mn
Jun 30, 2024 206.98 Mn
Mar 31, 2024 217.58 Mn
Dec 31, 2023 226.30 Mn
Sep 30, 2023 232.57 Mn
Jun 30, 2023 240.27 Mn
Mar 31, 2023 249.26 Mn
Dec 31, 2022 254.36 Mn
Sep 30, 2022 260.12 Mn
Jun 30, 2022 266.32 Mn
Mar 31, 2022 273.54 Mn
Dec 31, 2021 288.11 Mn
Sep 30, 2021 285.63 Mn